H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE)

July 9, 2026 6:52 AM

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $11.00 price target on Niagen Bioscience (NASDAQ: NAGE).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found